[HCV antibodies in selected patient groups and blood donors].
In a multicenter study in three eastern German blood banks, we searched for HCV antibodies in polytransfused patients, unpaid donors, hemodialysis patients and hemophiliacs. The high seropositivity of HCV antibodies in polytransfused patients shows the danger of the transmission of HCV through the transfusion of blood. Therefore, blood banks should consider making HCV antibody screening of the blood of donors a part of the policy to reduce NANB PTH.
Courault
K
K
Bezirks-Institut für Blutspende- und Transfusionswesen Berlin.
Lisse
C
C
Ehrenberg
M
M
Stolle
K
K
Brandstädter
W
W
Fritzsche
L
L
D001771:Blood Banks / Q000706:statistics & numerical data*; D001782:Blood Donors / Q000706:statistics & numerical data*; D003430:Cross-Sectional Studies; D004797:Enzyme-Linked Immunosorbent Assay; D005858:Germany / Q000453:epidemiology; D006467:Hemophilia A / Q000276:immunology; D016174:Hepacivirus / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis*; D006526:Hepatitis C / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D015994:Incidence; D006435:Renal Dialysis
D006508:Hepatitis Antibodies
HCV-Antikörper bei ausgewählten Patienten-gruppen und Blutspendern.